• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝集素通过与病毒糖蛋白复合物上特定连接的糖基化位点相互作用来增强病毒进入。

agglutinin enhances entry through interactions at specific -linked glycosylation sites on the virus glycoprotein complex.

作者信息

Duncan Joshua D, Pathak Monika, King Barnabas J, Bamber Holly, Radford Paul, Dey Jayasree, Richardson Charlotte, Astbury Stuart, McClure Patrick, Ball Jonathan K, Urbanowicz Richard A, Tarr Alexander W

机构信息

School of Life Sciences, Faculty of Medicine and Health Sciences, The University of Nottingham, Nottingham, UK.

Wolfson Centre for Global Virus Research, The University of Nottingham, Nottingham, UK.

出版信息

J Gen Virol. 2025 Jun;106(6). doi: 10.1099/jgv.0.002120.

DOI:10.1099/jgv.0.002120
PMID:40476860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12210185/
Abstract

Entry of e (EBOV) into a host cell is a complex process requiring interactions between the viral glycoproteins (GPs) and cellular factors. These entry factors are cell-specific and can include cell surface lectins and phosphatidylserine receptors. Niemann-Pick type C1 is critical to the late stage of the entry process. Entry has been demonstrated to be enhanced by interactions between the virion and surface-expressed lectins, which interact with carbohydrate moieties attached to the GP. In addition, soluble lectins, including mannose-binding lectin, can enhance entry . However, the mechanism of lectin-mediated enhancement remains to be defined. This study investigated the possibility that plant lectins, agglutinin (WFA), soybean agglutinin (SBA) and agglutinin (GNA), which possess different carbohydrate-binding specificities, influence EBOV entry. WFA was observed to potently enhance entry of lentiviral pseudotype viruses (PVs) expressing the GP of three species [Zaire, Sudan () and Reston ()], with the greatest impact on EBOV. SBA had a modest enhancing effect on entry that was specific to EBOV, whilst GNA had no impact on the entry of any of the species. None of the lectins enhanced the entry of control PVs expressing the surface proteins of other RNA viruses tested. WFA was demonstrated to bind directly with the EBOV-GP via the glycans, and mutational analysis implicated N as contributing to the interaction. Furthermore, enhancement was observed in both human and bat cell lines, indicating a highly conserved mechanism of action. We conclude that the binding of WFA to EBOV-GP through interactions including the glycan at N results in GP alterations that enhance entry, providing evidence of a mechanism for lectin-mediated virus entry enhancement. Targeting lectin-ligand interactions presents a potential strategy for restricting entry.

摘要

埃博拉病毒(EBOV)进入宿主细胞是一个复杂的过程,需要病毒糖蛋白(GPs)与细胞因子之间相互作用。这些进入因子具有细胞特异性,可包括细胞表面凝集素和磷脂酰丝氨酸受体。尼曼-匹克C1型蛋白对进入过程的后期至关重要。已证明病毒粒子与表面表达的凝集素之间的相互作用可增强进入,这些凝集素与附着在GP上的碳水化合物部分相互作用。此外,包括甘露糖结合凝集素在内的可溶性凝集素也可增强进入。然而,凝集素介导增强作用的机制仍有待确定。本研究调查了具有不同碳水化合物结合特异性的植物凝集素,即荆豆凝集素(WFA)、大豆凝集素(SBA)和雪花莲凝集素(GNA)影响EBOV进入的可能性。观察到WFA能有效增强表达三种埃博拉病毒毒株[扎伊尔型、苏丹型()和莱斯顿型()]GP的慢病毒假型病毒(PVs)的进入,对EBOV的影响最大。SBA对EBOV特异性的进入有适度增强作用,而GNA对任何一种埃博拉病毒毒株的进入均无影响。这些凝集素均未增强表达所测试的其他RNA病毒表面蛋白的对照PVs的进入。已证明WFA通过聚糖直接与EBOV-GP结合,突变分析表明N参与了这种相互作用。此外,在人和蝙蝠细胞系中均观察到增强作用,表明作用机制高度保守。我们得出结论,WFA通过包括N处聚糖在内的相互作用与EBOV-GP结合,导致GP改变从而增强进入,这为凝集素介导的病毒进入增强机制提供了证据。靶向凝集素-配体相互作用为限制埃博拉病毒进入提供了一种潜在策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/acee7a3d00d9/jgv-106-02120-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/3bd90887af39/jgv-106-02120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/e9070c920865/jgv-106-02120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/05d285b5d9ce/jgv-106-02120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/b037f03e5587/jgv-106-02120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/6638fcd4804e/jgv-106-02120-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/acee7a3d00d9/jgv-106-02120-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/3bd90887af39/jgv-106-02120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/e9070c920865/jgv-106-02120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/05d285b5d9ce/jgv-106-02120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/b037f03e5587/jgv-106-02120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/6638fcd4804e/jgv-106-02120-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe80/12210185/acee7a3d00d9/jgv-106-02120-g006.jpg

相似文献

1
agglutinin enhances entry through interactions at specific -linked glycosylation sites on the virus glycoprotein complex.凝集素通过与病毒糖蛋白复合物上特定连接的糖基化位点相互作用来增强病毒进入。
J Gen Virol. 2025 Jun;106(6). doi: 10.1099/jgv.0.002120.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.通过纤维胶凝蛋白-1与糖蛋白(GP)粘蛋白结构域的相互作用增强埃博拉病毒感染
J Virol. 2016 May 12;90(11):5256-5269. doi: 10.1128/JVI.00232-16. Print 2016 Jun 1.
4
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
5
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.

本文引用的文献

1
Multiple cell types support productive infection and dynamic translocation of infectious Ebola virus to the surface of human skin.多种细胞类型支持埃博拉病毒的有效感染以及感染性埃博拉病毒向人体皮肤表面的动态转运。
Sci Adv. 2025 Jan 3;11(1):eadr6140. doi: 10.1126/sciadv.adr6140. Epub 2025 Jan 1.
2
The hepatitis C virus envelope protein complex is a dimer of heterodimers.丙型肝炎病毒包膜蛋白复合物是异二聚体的二聚体。
Nature. 2024 Sep;633(8030):704-709. doi: 10.1038/s41586-024-07783-5. Epub 2024 Sep 4.
3
The west Africa Ebola virus disease outbreak: 10 years on.
西非埃博拉病毒病疫情:十年之后。
Lancet Glob Health. 2024 Jul;12(7):e1081-e1083. doi: 10.1016/S2214-109X(24)00129-3. Epub 2024 Mar 22.
4
Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature.假型病毒与真实病毒中和测定之间的相关性:文献的系统评价和荟萃分析。
Front Immunol. 2023 Sep 18;14:1184362. doi: 10.3389/fimmu.2023.1184362. eCollection 2023.
5
Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation.系统转录分析人类细胞系的基因表达图谱和肿瘤代表性。
Nat Commun. 2023 Sep 5;14(1):5417. doi: 10.1038/s41467-023-41132-w.
6
Ebola virus disease: A narrative review.埃博拉病毒病:一篇叙述性综述。
Microb Pathog. 2023 Aug;181:106213. doi: 10.1016/j.micpath.2023.106213. Epub 2023 Jun 23.
7
Glycan shield of the ebolavirus envelope glycoprotein GP.埃博拉病毒包膜糖蛋白 GP 的聚糖盾。
Commun Biol. 2022 Aug 4;5(1):785. doi: 10.1038/s42003-022-03767-1.
8
A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion.一种在 2013-2016 年埃博拉病毒流行期间出现的糖蛋白突变改变了蛋白水解作用并加速了膜融合。
mBio. 2021 Feb 16;12(1):e03616-20. doi: 10.1128/mBio.03616-20.
9
Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapy.基于理性设计的丙型肝炎病毒(HCV) p7 通道活性抑制剂揭示了双模式抗病毒治疗的前景。
Elife. 2020 Nov 10;9:e52555. doi: 10.7554/eLife.52555.
10
Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies.用埃博拉病毒糖蛋白对 VSV 进行假型化比使用 HIV-1 更能评估中和抗体。
Sci Rep. 2020 Aug 31;10(1):14289. doi: 10.1038/s41598-020-71225-1.